C. Deligny

4.1k total citations
59 papers, 679 citations indexed

About

C. Deligny is a scholar working on Rheumatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, C. Deligny has authored 59 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 15 papers in Pathology and Forensic Medicine and 15 papers in Epidemiology. Recurrent topics in C. Deligny's work include Systemic Lupus Erythematosus Research (12 papers), Systemic Sclerosis and Related Diseases (12 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). C. Deligny is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Systemic Sclerosis and Related Diseases (12 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). C. Deligny collaborates with scholars based in Martinique, France and Guadeloupe. C. Deligny's co-authors include S. Arfi, G. Jean-Baptiste, Dominique Farge, Michel De Bandt, Zora Marjanovic, G. Pugnet, E. Clyti, Olivier Benvéniste, Pierre Charles and Loı̈c Guillevin and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

C. Deligny

50 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Deligny Martinique 15 207 199 181 155 135 59 679
F. Cordoliani France 18 115 0.6× 309 1.6× 119 0.7× 211 1.4× 195 1.4× 63 876
Thomas Barba France 12 126 0.6× 289 1.5× 199 1.1× 118 0.8× 177 1.3× 33 749
S. Durupt France 14 116 0.6× 201 1.0× 309 1.7× 70 0.5× 307 2.3× 65 849
Ann Knight Sweden 17 207 1.0× 337 1.7× 418 2.3× 110 0.7× 68 0.5× 30 937
Marco Antonio Yamazaki‐Nakashimada Mexico 18 391 1.9× 112 0.6× 233 1.3× 51 0.3× 108 0.8× 92 926
Susumu Nishinarita Japan 15 334 1.6× 106 0.5× 72 0.4× 117 0.8× 107 0.8× 66 695
Joaquín Belzunegui Spain 14 250 1.2× 538 2.7× 230 1.3× 71 0.5× 93 0.7× 38 829
Julio Granados Mexico 14 184 0.9× 135 0.7× 114 0.6× 52 0.3× 71 0.5× 36 651
J. Lisa United States 22 281 1.4× 75 0.4× 247 1.4× 99 0.6× 166 1.2× 76 1.3k
Jean-Michel Ristori France 15 200 1.0× 542 2.7× 78 0.4× 90 0.6× 108 0.8× 42 928

Countries citing papers authored by C. Deligny

Since Specialization
Citations

This map shows the geographic impact of C. Deligny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Deligny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Deligny more than expected).

Fields of papers citing papers by C. Deligny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Deligny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Deligny. The network helps show where C. Deligny may publish in the future.

Co-authorship network of co-authors of C. Deligny

This figure shows the co-authorship network connecting the top 25 collaborators of C. Deligny. A scholar is included among the top collaborators of C. Deligny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Deligny. C. Deligny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thoreau, Benjamin, Philippe Chafey, Guilhem Clary, et al.. (2025). Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD). Lara D. Veeken. 64(6). 4041–4050.
2.
Felix, A., Fréderique Delion, Rémi Bellance, et al.. (2023). Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies. Pediatric Rheumatology. 21(1). 113–113. 3 indexed citations
3.
Morel, Nathalie, K. Lévesque, Alice Maltret, et al.. (2022). Health Outcomes of 215 Mothers of Children With Autoimmune Congenital Heart Block: Analysis of the French Neonatal Lupus Syndrome Registry. The Journal of Rheumatology. 49(10). 1124–1130. 7 indexed citations
4.
Felix, A., Fréderique Delion, Moustapha Dramé, et al.. (2022). Systemic lupus of pediatric onset in Afro-Caribbean children: a cohort study in the French West Indies and French Guiana. Pediatric Rheumatology. 20(1). 95–95. 4 indexed citations
5.
Couderc, Thérèse, et al.. (2021). The Clinicopathological Spectrum of Kidney Lesions in Chikungunya Fever: A Report of 5 Cases With Kidney Biopsy. American Journal of Kidney Diseases. 78(6). 902–906. 7 indexed citations
6.
Pugnet, G., Zora Marjanovic, C. Deligny, et al.. (2018). Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis. The Journal of Rheumatology. 45(9). 1273–1280. 18 indexed citations
7.
Coiffier, Guillaume, A. Bleuzen, Michel De Bandt, et al.. (2018). What is the best salivary gland ultrasonography scoring methods for the diagnosis of primary or secondary Sjögren's syndromes?. Joint Bone Spine. 86(2). 211–217. 27 indexed citations
9.
Najioullah, Fatiha, et al.. (2016). Two cases of thrombocytopenic purpura at onset of Zika virus infection. Journal of Clinical Virology. 83. 61–62. 20 indexed citations
10.
Jamme, Matthieu, C. Deligny, Marc Busson, et al.. (2016). Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors. PLoS ONE. 11(7). e0156679–e0156679. 34 indexed citations
11.
Benhamou, Y., Gilles Paintaud, Élie Azoulay, et al.. (2016). Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. American Journal of Hematology. 91(12). 1246–1251. 39 indexed citations
13.
Baubion, É., et al.. (2015). Pyoderma gangrenosum et aortite neutrophilique précédant l’apparition d’une polyarthrite rhumatoïde. Annales de Dermatologie et de Vénéréologie. 142(6-7). 425–429. 1 indexed citations
14.
Diéval, C., C. Deligny, Alain Meyer, et al.. (2015). Myocarditis in Patients With Antisynthetase Syndrome. Medicine. 94(26). e798–e798. 40 indexed citations
15.
Amoura, Zahir, C. Deligny, M. Hamidou, et al.. (2014). Coût du lupus systémique en France des patients adultes avec une maladie active et traitée (étude LUCIE). La Revue de Médecine Interne. 35(11). 700–708. 2 indexed citations
16.
Charles, Pierre, A. Néel, N. Tieulié, et al.. (2013). Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Lara D. Veeken. 53(3). 532–539. 90 indexed citations
17.
Deligny, C., E. Clyti, D. Sainte‐Marie, et al.. (2010). Incidence of chronic cutaneous lupus erythematosus in French Guiana: A retrospective population‐based study. Arthritis Care & Research. 62(2). 279–282. 15 indexed citations
18.
19.
Baubion, É., et al.. (2008). Nécrose musculaire du diabétique : trois cas Afro-caribéens. La Revue de Médecine Interne. 30(2). 161–164.
20.
Deligny, C., et al.. (2002). Lupus systémique en Martinique : enquête épidémiologique. La Revue de Médecine Interne. 23(1). 21–29. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026